Sibylle Loibl Selected Research

Sibylle Loibl Research Topics

Disease

277	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2002
129	Neoplasms (Cancer) 01/2024 - 05/2002
41	Triple Negative Breast Neoplasms 04/2024 - 06/2014
32	Pathologic Complete Response 11/2023 - 04/2010
15	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2008
10	Neutropenia 11/2023 - 07/2010
10	Carcinoma (Carcinomatosis) 11/2017 - 05/2002
8	Fatigue 11/2023 - 01/2006
8	Brain Neoplasms (Brain Tumor) 01/2023 - 02/2009
8	Febrile Neutropenia 01/2021 - 04/2010
7	Diarrhea 06/2023 - 04/2010
6	Disease Progression 06/2023 - 07/2008
6	Infections 01/2020 - 11/2011
5	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2023 - 04/2012
5	Leukopenia 01/2021 - 07/2015
5	Residual Neoplasm 01/2019 - 12/2006
4	Exanthema (Rash) 06/2023 - 02/2012
4	Hypertension (High Blood Pressure) 01/2020 - 01/2012
4	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2006
3	Inflammatory Breast Neoplasms 01/2021 - 01/2010
3	Anemia 01/2021 - 01/2006
3	Amenorrhea 01/2021 - 06/2011
3	Vomiting 01/2021 - 01/2020
3	Nausea 01/2021 - 01/2020
3	Cardiotoxicity 12/2020 - 01/2008
3	Circulating Neoplastic Cells 01/2018 - 05/2010
3	Thrombocytopenia (Thrombopenia) 07/2015 - 07/2013

Drug/Important Bio-Agent (IBA)

71	Hormones (Hormone)IBA 12/2023 - 01/2006
46	Trastuzumab (Herceptin)FDA Link 01/2024 - 02/2009
36	taxaneIBA 10/2021 - 01/2008
35	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2008
33	AnthracyclinesIBA 01/2021 - 01/2008
32	human ERBB2 proteinIBA 02/2024 - 01/2009
30	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2006
23	ErbB Receptors (EGF Receptor)IBA 11/2023 - 10/2002
22	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2008
21	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 11/2007
19	Estrogen ReceptorsIBA 02/2023 - 02/2007
18	Capecitabine (Xeloda)FDA Link 11/2023 - 04/2008
17	Phenobarbital (Luminal)FDA Link 01/2024 - 11/2010
17	Docetaxel (Taxotere)FDA Link 03/2023 - 01/2006
14	palbociclibIBA 11/2023 - 07/2015
14	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2002
13	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 07/2008
12	130-nm albumin-bound paclitaxelIBA 11/2023 - 07/2010
12	Fulvestrant (Faslodex)FDA Link 06/2023 - 03/2015
12	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2011
10	Epidermal Growth Factor (EGF)IBA 12/2023 - 10/2002
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2006
9	Lapatinib (GW572016)FDA Link 08/2019 - 01/2008
8	Messenger RNA (mRNA)IBA 01/2021 - 02/2013
7	pertuzumabIBA 01/2024 - 07/2015
7	Taxoids (Taxanes)IBA 02/2016 - 01/2008
6	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2019
6	sacituzumab govitecanIBA 10/2023 - 01/2021
6	Progesterone Receptors (Progesterone Receptor)IBA 02/2023 - 01/2009
5	Aromatase InhibitorsIBA 12/2023 - 01/2016
5	Cyclin-Dependent Kinase 4IBA 06/2023 - 01/2017
5	Tamoxifen FDA LinkGeneric 01/2023 - 08/2005
5	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2016
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2022 - 06/2011
5	ParaffinIBA 07/2020 - 01/2010
5	Formaldehyde (Formol)FDA Link 07/2020 - 01/2010
5	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2003
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 08/2005
5	Goserelin (Zoladex)FDA Link 01/2017 - 08/2005
4	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2021
4	tucatinibIBA 01/2023 - 06/2018
4	Ado-Trastuzumab EmtansineIBA 09/2022 - 01/2019
4	Vinorelbine (Navelbine)FDA LinkGeneric 08/2022 - 04/2008
4	Monoclonal AntibodiesIBA 06/2018 - 04/2003
4	Bendamustine Hydrochloride FDA Link 12/2011 - 01/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 09/2002
3	durvalumabIBA 04/2024 - 01/2021
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023 - 07/2015
3	Anastrozole (Arimidex)FDA LinkGeneric 12/2023 - 01/2016
3	Denosumab FDA Link 11/2023 - 01/2022
3	Ibandronic Acid (Boniva)FDA Link 11/2023 - 10/2011
3	neratinibIBA 01/2023 - 06/2018
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2018
3	eribulin FDA Link 08/2022 - 01/2019
3	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 01/2019
3	Estrogens (Estrogen)FDA Link 01/2021 - 01/2006
3	Letrozole (Femara)FDA LinkGeneric 01/2021 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2020 - 10/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2016
3	Cytotoxins (Cytolysins)IBA 01/2019 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 01/2011
3	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 11/2007
3	LipidsIBA 04/2014 - 05/2011
2	Surface Antigens (Surface Antigen)IBA 02/2024 - 01/2021

Therapy/Procedure

118	Neoadjuvant Therapy 02/2024 - 01/2006
106	Therapeutics 12/2023 - 10/2002
91	Drug Therapy (Chemotherapy) 02/2024 - 08/2005
16	Adjuvant Chemotherapy 01/2024 - 01/2008
6	Radiotherapy 02/2024 - 02/2009
6	Aftercare (After-Treatment) 06/2023 - 10/2011
5	Immunotherapy 04/2022 - 11/2017
4	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2010
3	Lymph Node Excision (Lymph Node Dissection) 10/2023 - 10/2019